Sansure Biotech Inc. (SHA:688289)

Sansure Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,224	13,001	11,187	12,747	23,600	45,580
Market Cap Growth	12.05%	16.22%	-12.24%	-45.99%	-48.22%	-
Enterprise Value	8,658	8,982	6,408	7,417	18,716	41,873
Last Close Price	21.29	22.39	18.79	20.31	35.34	67.09
PE Ratio	43.50	47.17	30.76	6.58	10.52	17.42
Forward PE	32.26	8.19	8.19	8.19	12.20	13.61
PS Ratio	7.92	8.92	11.11	1.98	5.23	9.57
PB Ratio	1.64	1.77	1.51	1.70	3.70	9.61
P/TBV Ratio	2.02	1.88	1.62	1.72	3.73	9.67
P/FCF Ratio	-	-	-	6.37	15.69	17.99
P/OCF Ratio	33.37	47.37	256.93	4.98	12.57	17.25
EV/Sales Ratio	5.61	6.16	6.36	1.15	4.15	8.79
EV/EBITDA Ratio	29.86	33.53	80.30	3.27	7.28	13.52
EV/EBIT Ratio	66.41	70.58	-	3.38	7.41	13.64
EV/FCF Ratio	-120.10	-	-	3.71	12.44	16.53
Debt / Equity Ratio	0.11	0.06	0.01	0.00	0.00	0.01
Debt / EBITDA Ratio	2.91	1.53	0.40	0.01	0.01	0.02
Debt / FCF Ratio	-	-	-	0.01	0.01	0.02
Asset Turnover	0.17	0.17	0.11	0.79	0.72	1.56
Inventory Turnover	0.85	0.73	0.77	8.04	3.97	5.69
Quick Ratio	4.07	7.05	5.98	4.48	8.29	6.91
Current Ratio	4.44	7.67	6.47	4.79	8.99	7.38
Return on Equity (ROE)	3.12%	3.06%	4.66%	27.88%	40.31%	98.69%
Return on Assets (ROA)	0.88%	0.93%	-0.15%	16.86%	25.17%	62.94%
Return on Capital (ROIC)	1.00%	1.04%	-0.18%	19.68%	28.20%	71.62%
Return on Capital Employed (ROCE)	1.60%	1.60%	-	28.90%	39.30%	64.40%
Earnings Yield	2.34%	2.12%	3.25%	15.19%	9.50%	5.74%
FCF Yield	-0.59%	-1.13%	-3.11%	15.69%	6.37%	5.56%
Dividend Yield	2.47%	2.34%	2.46%	6.39%	2.15%	1.13%
Payout Ratio	95.95%	97.39%	110.10%	33.92%	19.61%	11.51%
Buyback Yield / Dilution	-0.64%	0.05%	-0.26%	0.59%	-6.55%	-3.97%
Total Shareholder Return	1.83%	2.39%	2.20%	6.98%	-4.40%	-2.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.